Pfizer
BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year
November 16, 2020Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine
The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uฤur ลahin, Professor …
Israel to reserve 8m doses of Pfizer/BioNTech’s COVID-19 vaccine
November 13, 2020Manufacturing and Production, Medical Communications BioNTech, COVID-19, Pfizer, Vaccine, israel
Israeli Health Minister Yuli Edelstein has confirmed the nationโs plans to strike an agreement with Pfizer to secure eight million …
Pfizer CEO cashes in shares for $5.6m following strong Phase 3 COVID-19 vaccine data
November 12, 2020Sales and Marketing COVID-19, Pfizer, Vaccine, pharma
With the news that Pfizer and BioNTechโs COVID-19 vaccine candidate demonstrated 90% efficacy in a Phase 3 interim analysis, it …
Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis
November 10, 2020Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …
Pfizer wonโt apply for COVID-19 vaccine emergency authorisation until after US election, CEO says
October 19, 2020Sales and Marketing COVID-19, Pfizer, US, Vaccine
The Chief Executive Officer of Pfizer has said that the company will now submit their vaccine for FDA Emergency Use …
Bavencio/axitinib combo approved for NHS Scotland in advanced renal cell carcinoma
October 13, 2020Manufacturing and Production, Sales and Marketing Merck, NHS, Pfizer, SMC
The Scottish Medicines Consortium (SMC) has given the go-ahead to Merck KGaA and Pfizerโs combination of their PD-L1 inhibitor immunotherapy …
EMA launches rolling regulatory review of Pfizer and BioNTech’s COVID-19 vaccine
October 7, 2020Research and Development, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine
European Medicines Agency has launched a โrolling reviewโ of the promising COVID-19 vaccine candidate BNT162b2 currently in development from BioNTech …
Pfizerโs coronavirus vaccine shows moderate side-effects in clinical study
September 16, 2020Research and Development COVID-19, Pfizer, Pfizer vaccine, coronavirus vaccine
Pfizer has said that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side …
Pfizer CEO says companyโs COVID-19 vaccine will be available this year if FDA approves the candidate by October
September 14, 2020Sales and Marketing Pfizer, Pfizer vaccine, Vaccine
Albert Bourla, the CEO of Pfizer, has said that the companyโs vaccine for COVID-19 could be used by the general …
MHRA gives OK to Bavencio for first-line maintenance of advanced bladder cancer via the Early Access to Medicines Scheme
September 3, 2020Sales and Marketing Bavencio, MHRA, Merck, Pfizer, UK, eams, pharma
It has been revealed that Bavencio (avelumab), jointly developed by Merck KGaA and Pfizer, has been approved by the UK …
Former MP and Labour leadership candidate joins Bristol Myers Squibb
August 20, 2020Business Services Big Pharma, Pfizer
Owen Smith, the former Labour MP and leadership candidate, has joined Bristol Myers Squibb as its UK Government Relations Director. Smith …
Bavencio+Inylta combo approved or Cancer Drugs Fund in advanced renal cell carcinoma
July 31, 2020Medical Communications, Sales and Marketing Merck, NICE, Pfizer, pharma
NICE has revealed that a combination of Merck KGaAโs Bavencio (avelumab) and Pfizerโs Inlyta (axitinib) will be made available as …
Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study
July 22, 2020Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma
BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …
Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate
July 3, 2020Medical Communications, Research and Development BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech have revealed new efficacy findings on the โmost advancedโ of four candidates being worked on as part …
Pfizer sues US for permission to help Medicare patients with rare heart conditions
June 29, 2020Sales and Marketing Medicaid, Medicare, Pfizer
Pfizer has filed a lawsuit against the US government to allow it to directly help with the copayments of Medicare …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
